Data Tables


Sections I - VIII
I.Summary Tables
II.Deceased and Living Donor Characteristics
III.Deceased Donor Organ Recovery and Disposition
IV.Organ Procurement Organization Tables
V.Kidney Tables
VI.Pancreas Transplant Alone (PTA) Tables
VII.Pancreas After Kidney (PA k) Tables
VIII.Kidney-Pancreas Tables
Sections IX - XV
IX.Liver Tables
X.Intestine Tables
XI.Heart Tables
XII.Lung Tables
XIII.Heart-Lung Tables
XIV.Donor and Recipient Tumor Tables
XV.Supplementary Tables
 Technical Notes and Analytic Methods
 All Data Tables (351 K)



View HTMLView PDF

Section VII

7.1aWaiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active Waitlist Patients, 1997 to 2006Table 7.1a (37 k)
Age
Blood Type
Residency
Gender
Race
Previous Transplant Same Organ
Time on Waiting List
7.1bWaiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active and Inactive Patient Comparison, 2002 to 2006Table 7.1b (33 k)
Age
Gender
Race
Time on Waiting List
7.2Time to Transplant, 1997 to 2006 New Pancreas After Kidney (PAK) Waiting List RegistrationsTable 7.2 (49 k)
Blood Type
Age
Gender
All Patient Types
Race
Residency
7.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Pancreas After Kidney (PAK) Waiting ListTable 7.3 (39 k)
Age
Blood Type
Gender
Race
7.4Transplant Recipient Characteristics, 1997 to 2006 Pancreas After Kidney (PAK) RecipientsTable 7.4 (39 k)
Age
Blood Type
Residency
Gender
Race
Cold Ischemic Time
Hospitalized at Tx
Previous Transplant Same Organ
Payment Source
7.5Incidence of Transplant, 1997 to 2006 Pancreas After Kidney (PAK) Transplants per 1 Million PopulationTable 7.5 (29 k)
7.6aImmunosuppression Use for Induction, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6a (29 k)
7.6bImmunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6b (31 k)
7.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6c (29 k)
7.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6d (30 k)
7.6eImmunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6e (31 k)
7.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6f (31 k)
7.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6g (31 k)
7.6hPersistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6h (33 k)
7.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6i (30 k)
7.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Pancreas After Kidney (PAK) TransplantationTable 7.7 (64 k)
Blood Type
Residency
Gender
Race
Donor Age
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
7.8Adjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 7.8 (30 k)
Age
Gender
Race
7.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) TransplantsTable 7.9 (22 k)
7.10Unadjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 7.10 (37 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
7.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) TransplantsTable 7.11 (22 k)
7.12Adjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 7.12 (30 k)
Age
Gender
Race
7.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) TransplantsTable 7.13 (22 k)
7.14Unadjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 7.14 (37 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
7.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) TransplantsTable 7.15 (22 k)
7.16Prevalence of People Living with a Functioning Transplant at End of Year Pancreas After Kidney (PAK) Recipients, 1997 to 2005Table 7.16 (36 k)
Blood Type
Residency
Gender
Race
Age
Hospitalized at Tx
Previous Transplant Same Organ
7.17Transplants by State and Transplant Center, 1997 to 2006 Pancreas After Kidney (PAK)Table 7.17 (66 k)